GlassScriptPhysician profile
David W Stevens
NPI 1902941479
$107,950.87
in general payments reported to CMS, 2019-2025
38 companies · $39K in 2025
The $39K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,730 · 2020: $1,561 · 2021: $1,663 · 2022: $2,107 · 2023: $41K · 2024: $19K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $81K · Travel and Lodging: $17K · Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $80,550.00 |
| Travel and Lodging | $16,724.69 |
| Food and Beverage | $1,613.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $57,475.76 | 2024-2025 | Mobi-C Plug & Fit US, Vital, Roi-A |
| Zimvie INC. | $39,015.27 | 2022-2023 | |
| Globus Medical, INC. | $4,097.84 | 2019-2023 | Clavicular Fracture Fixation |
| Zimmer Biomet Holdings, INC. | $2,156.19 | 2019-2020 | |
| Nuvasive, INC. | $1,622.13 | 2019 | |
| Nexxt Spine LLC | $1,442.88 | 2023-2024 | Nexxt Spine Product Portfolio, Nexxt Coronal Tapered Cage |
| Centinel Spine, LLC | $543.65 | 2019-2023 | Prodisc C Vivo |
| Nevro Corp. | $280.33 | 2019-2022 | |
| Alafair Biosciences, INC. | $119.40 | 2024 | Versawrap |
| Teva Pharmaceuticals USA, INC. | $114.36 | 2019-2022 | |
| Cerapedics INC. | $106.97 | 2019-2025 | I-Factor Peptide Enhanced Bone Graft |
| Relievant Medsystems, INC. | $86.61 | 2022-2023 | Intracept |
| Amgen INC. | $85.91 | 2019-2025 | Evenity, Prolia |
| Radius Health, INC. | $72.63 | 2020-2021 | |
| Depuy Synthes Sales INC. | $70.63 | 2020-2025 | Vivigen Mis Delivery System |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.